Nasdaq Beats Q1 Revenue Estimates with Strong FinTech and Index Performance
Nasdaq (NDAQ) reported a strong first quarter, surpassing revenue expectations with significant contributions from its financial technology and index businesses. The company's financial technology unit...
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
The market's excited for these stocks, but there's no rush to buy them.